688443 fundamentals
An in-depth look to CHONGQING GENRIX BIOPHARMACEUTICAL operating, investing, and financing activities
688443 free cash flow for Q1 25 is -116.86 M CNY. For 2024, 688443 free cash flow was -620.75 M CNY and operating cash flow was -575.44 M CNY.
Q1 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CNY
Q1 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
TTM